Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPS5850222B2 - Sesquiterpene derivative compounds - Google Patents
[go: Go Back, main page]

JPS5850222B2 - Sesquiterpene derivative compounds - Google Patents

Sesquiterpene derivative compounds

Info

Publication number
JPS5850222B2
JPS5850222B2 JP4533980A JP4533980A JPS5850222B2 JP S5850222 B2 JPS5850222 B2 JP S5850222B2 JP 4533980 A JP4533980 A JP 4533980A JP 4533980 A JP4533980 A JP 4533980A JP S5850222 B2 JPS5850222 B2 JP S5850222B2
Authority
JP
Japan
Prior art keywords
ether
compound
solvent
layer
distilled
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP4533980A
Other languages
Japanese (ja)
Other versions
JPS55153780A (en
Inventor
弘幸 秋田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RIKEN
Original Assignee
RIKEN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RIKEN filed Critical RIKEN
Priority to JP4533980A priority Critical patent/JPS5850222B2/en
Publication of JPS55153780A publication Critical patent/JPS55153780A/en
Publication of JPS5850222B2 publication Critical patent/JPS5850222B2/en
Expired legal-status Critical Current

Links

Landscapes

  • Furan Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

【発明の詳細な説明】 本発明は、構造式: で表わされる新規なセスキテルペン誘導体化合物に関す
るものである。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel sesquiterpene derivative compound represented by the structural formula:

本発明の化合物は、次の方法により得ることができる。The compound of the present invention can be obtained by the following method.

出発物質のジテルペン系フェノール誘導体は、一般式: (ただし、式中、Rは水素又はイソプロピル基を示す。The starting diterpene phenol derivative has the general formula: (However, in the formula, R represents hydrogen or an isopropyl group.

)で表わされ、芳香性C環を有するジテルペン系誘導体
、特にl−アビエチン酸より容易に導くことができる。
), and can be easily derived from diterpene derivatives having an aromatic C ring, especially l-abietic acid.

l−アビエチン酸は、次のような構造式を有し、検相類
樹脂の主成分として、容易且つ廉価に入手することがで
き、すでにその立体構造を含めて構造式も、上記の如く
確定され、その全合成も達成されている。
l-Abietic acid has the following structural formula and can be easily and inexpensively obtained as the main component of phase detection resins, and the structural formula including its three-dimensional structure has already been determined as described above. and its total synthesis has also been achieved.

(W、H,5chuller et al : J
。Am、Chem、 Soc ++、83.2563(
1961)、E、Wenkert et al :
J、Am、Chem、 Soc 、、86.2038
(1964)参照〕 ☆ 又、l−アビエチン酸(A)から誘導出来る化合物とし
ては、例えば、皮膚生菌類(例えば、Tricophy
ton、 Microsporum )に対して抗カビ
活性を示すシンナモライド〔B〕を始めとするドリマン
型セスキテルペン(drimane typeses
quiterpene ) (C) 〜(G )が知ら
れている。
(W, H, 5chuller et al: J
. Am, Chem, Soc ++, 83.2563 (
1961), E. Wenkert et al.
J,Am,Chem,Soc,,86.2038
(1964)] ☆ In addition, compounds that can be derived from l-abietic acid (A) include, for example, skin fungi (such as Tricophy
ton, Microsporum), including cinnamoride [B], which exhibits antifungal activity against drimane types
Quiterpene) (C) to (G) are known.

(C):コンフエルテイフオリン (Confertifolln )、〔D〕:イソドリ
メニン(I sodrimenin )、〔E〕ニトリ
メニン(Drimenin)、〔F〕:パルディビオラ
イド(Valdiviolide )、〔G〕:ウィン
チリン(Winterin ) 本発明の目的化合物は、前記コンフェルティフォリン〔
C〕と同じ骨格を有することから、上記天然の抗カビ活
性と同様の生理活性が期待されるものである。
(C): Confertifolln, [D]: Isodrimenin, [E] Nitrimenin, [F]: Valdiviolide, [G]: Wint erin) book The object compound of the invention is the above-mentioned Confertifolin [
Since it has the same skeleton as C], it is expected to have the same physiological activity as the natural antifungal activity mentioned above.

(A)からドリマン型セスキテルペン群へ変換するには
、(A)から容易に得られるデヒドロアビエチン酸の芳
香性C環を(a)方向で開裂することが必要である。
In order to convert (A) to the Doliman-type sesquiterpene group, it is necessary to cleave the aromatic C ring of dehydroabietic acid, which is easily obtained from (A), in the (a) direction.

一方、ドリマン型セスキテルペン群の化合物の中で一部
は全合成されたものもあるが、何れも合成工程が長く、
収率も悪いのが現状である。
On the other hand, some of the compounds of the Drimane-type sesquiterpene group have been completely synthesized, but the synthesis process is long and
At present, the yield is also poor.

(E、Wenkert &D、 P、 5trike
、 J 、 Am。
(E, Wenkert & D, P, 5trike
, J., Am.

Chem、Soc、、86.2044(1964)、G
Chem, Soc, 86.2044 (1964), G.
.

Brieger 、 Tetrahedron Let
ters 11965.4429、Y、Kitahar
a et al、 Chem。
Brieger, Tetrahedron Let
ters 11965.4429, Y, Kitahar
a et al., Chem.

Commun、、1969 342Synthesis
1970゜257、Bull 、 Chem、 Soc
、 Japan 、、43.1268(1970)、
Tetrahedron Letters1971.1
961、Tetrahedron Letters1
972.4257等参照〕 以下に、本発明方法を詳述する。
Commun,, 1969 342Synthesis
1970°257, Bull, Chem, Soc
, Japan, , 43.1268 (1970),
Tetrahedron Letters1971.1
961, Tetrahedron Letters1
972.4257, etc.] The method of the present invention will be described in detail below.

まず、本発明の出発物質のジテルペン系フェノール誘導
体は、例えば次の如き既知の方法に準じてl−アビエチ
ン酸〔A〕から容易に得ることができる。
First, the diterpene-based phenol derivative as the starting material of the present invention can be easily obtained from l-abietic acid [A] according to the following known method, for example.

(A、Tahara and H,Akita、
Chem。Pharm、 Bull (Tokyo
) 23.1976(1975)、同23.1984(
1975)、日本薬学会第96年会1976年構演要旨
集第■分冊等参照〕 (1):メチル14−ヒドロキシ デヒドロアビエテー
ト(Methyl 14’ −hydroxydeh
ydroabietate )、 (2) :メチル14−ヒドロキシ デイソプロビルデ
ヒドロアビエテー) (Methyl 14−hyd
roxydeisopropyl dehydroa
bietate )かくして得られた出発物質、14−
ヒドロキシ体(1)又&狙2)を、オゾン酸化して芳香
環を開裂した後、種々の還元剤処理を行なって本発明の
目的化合物を得ることができる。
(A, Tahara and H, Akita,
Chem. Pharm, Bull (Tokyo
) 23.1976 (1975), 23.1984 (
(1): Methyl 14'-hydroxydeh
(2): Methyl 14-hyd
roxydeisopropyl dehydroa
bietate) The starting material thus obtained, 14-
The target compound of the present invention can be obtained by subjecting the hydroxy compound (1) and 2) to ozone oxidation to cleave the aromatic ring and then treating it with various reducing agents.

此の反応は溶媒中で行なうのが好ましくこの除用いる溶
媒は、クロロホルム、塩化メチレン、酢酸エチル等を用
いることができるが、特にCH2Cl2−CH30H(
1: 1)系を用いるのが有利である。
This reaction is preferably carried out in a solvent, and the solvent to be removed can be chloroform, methylene chloride, ethyl acetate, etc., but in particular CH2Cl2-CH30H (
It is advantageous to use a 1:1) system.

又用いるオゾンの量は大過剰を用いるのがよく、反応温
度は一80°C〜0℃の範囲が好ましい。
The amount of ozone used is preferably in large excess, and the reaction temperature is preferably in the range of -80°C to 0°C.

又、還元に用いる還元剤としては、接触還元(10%P
d−C触媒)、水素化ホウ素ナトリウム、亜硫酸ソーダ
、亜鉛−酢酸、ジメチルスルフィド等を用いることがで
きる。
In addition, as a reducing agent used for reduction, catalytic reduction (10% P
dC catalyst), sodium borohydride, sodium sulfite, zinc-acetic acid, dimethyl sulfide, and the like.

反応温度及び反応時間はそれぞれ、O℃〜30℃、30
分〜12時間が好ましい。
The reaction temperature and reaction time were 0°C to 30°C and 30°C, respectively.
Minutes to 12 hours are preferred.

溶媒は通常還元に用いられるものは一般に用いることが
できるが、CH2Cl2−CH30H,EtOH−H2
O、アセトン、酢酸、水等を用いるのが有利である。
As the solvent, those normally used for reduction can be used, but CH2Cl2-CH30H, EtOH-H2
Advantageously, O, acetone, acetic acid, water and the like are used.

上記還元剤のうち、例えば、10%Pd−C1亜硫酸ソ
ーダを用いた場合には、まずヒドロキシラクトン体3)
が得られるが、該化合物を、更に、例えば水素化ホウ素
ナトリウムで処理すれば、本発明の化合物であるラクト
ン体(4)を得ることができる。
Among the above reducing agents, for example, when using 10% Pd-C1 sodium sulfite, first the hydroxylactone form 3)
However, if the compound is further treated with, for example, sodium borohydride, the lactone compound (4), which is the compound of the present invention, can be obtained.

又、水素化ホウ素ナトリウムを用いた場合には、一挙に
本発明のラクトン体(4)を得ることができる。
Moreover, when sodium borohydride is used, the lactone compound (4) of the present invention can be obtained all at once.

次に上記合成法の具体例を挙げて説明すれば、次の如く
である。
Next, a specific example of the above synthesis method will be explained as follows.

すなわち、出発物質である14−ヒドロキシ体(1)又
は(2)をCH2Cl□−CH30H中ドライアイスア
セトン冷却下、オゾンを吹き込み、室温に戻して10%
Pd−Cを加えて、常圧接触還元に付す。
That is, the starting material 14-hydroxy compound (1) or (2) was cooled in dry ice acetone in CH2Cl□-CH30H, ozone was blown into it, the temperature was returned to room temperature, and the concentration was reduced to 10%.
Pd-C is added and subjected to atmospheric pressure catalytic reduction.

水素が吸収しなくなるまで接触還元を行ない、その後、
濾過する。
Catalytic reduction is carried out until hydrogen is no longer absorbed, and then
Filter.

F液を濃縮後残渣にエーテルを加え、エーテル層を10
%KOH溶液にて抽出する。
After concentrating solution F, ether was added to the residue, and the ether layer was diluted with
% KOH solution.

アルカリ層は10%HCI 溶液で酸性にしてクロロホ
ルムから抽出する。
The alkaline layer is acidified with 10% HCI solution and extracted from chloroform.

クロロホルム層及びエーテル層は各々飽和食塩水で洗浄
後、Na2SO4で脱水乾燥後、それぞれ溶媒を留去す
る。
The chloroform layer and the ether layer were each washed with saturated brine, dehydrated and dried over Na2SO4, and the solvent was distilled off.

クロロホルム層は溶媒留去後、更にジアゾメタン−エー
テル溶液を加えてメチル化後、エーテルを留去する。
After distilling off the solvent, the chloroform layer is further methylated by adding a diazomethane-ether solution, and then the ether is distilled off.

得られた油状物をシリカゲルカラムクロマトグラフィー
に付し、エーテルの溶出部をエーテル−n−ヘキサンか
ら再結晶すればヒドロキシラクトン体(3)を得る。
The obtained oil is subjected to silica gel column chromatography, and the ether eluate is recrystallized from ether-n-hexane to obtain hydroxylactone compound (3).

上記の方法に於いて、還元剤を10%Pd−Cに代えて
亜硫酸ナトリウムを用いて、同様の反応を行なってもヒ
ドロキシラクトン体3)が得られる。
In the above method, hydroxylactone compound 3) can also be obtained by performing the same reaction using sodium sulfite instead of 10% Pd-C as the reducing agent.

得られたヒドロキシラクトン体(3)を50%(V/V
) E t OHH20溶液に溶かし、水冷攪拌下、
NaBH4を加えて攪拌する。
The obtained hydroxylactone body (3) was reduced to 50% (V/V
) E t Dissolved in OHH20 solution and stirred under water cooling.
Add NaBH4 and stir.

その後、水を加えてエーテルから抽出する。Then add water and extract from ether.

エーテル層を飽和食塩水で洗浄後、Na25O譚脱水乾
燥して溶媒留去すると油状物のラクトン体(4)を得る
The ether layer was washed with saturated brine, dehydrated and dried over Na25O, and the solvent was distilled off to obtain an oily lactone (4).

又、出発物質の14−ヒドロキシ体1)を、ドライアイ
ス−アセトン冷却下、オゾンを吹き込み、室温に戻して
NaBH4−50%(v/V)EtOHH20を加えて
攪拌する。
Further, the starting material 14-hydroxy compound 1) was cooled with dry ice-acetone, blown with ozone, returned to room temperature, and NaBH4-50% (v/V) EtOH20 was added thereto and stirred.

その後、水を加えてエーテルから抽出する。Then add water and extract from ether.

エーテル飽和食塩水で洗浄後、Na2SO4で脱水乾燥
して溶媒を留去する。
After washing with ether saturated brine, dehydration and drying over Na2SO4 were carried out, and the solvent was distilled off.

残渣をシリカゲルカラムクロマトグラフィーに付し、石
油エーテル−エーテルの溶出部から油状物のラクトン体
(4)を得ることができる。
The residue is subjected to silica gel column chromatography, and an oily lactone (4) can be obtained from the petroleum ether-ether eluate.

これを図に表わせば、次の如くである。This can be expressed in a diagram as follows.

本発明の化合aflA4)の名称は次の如くである。The name of the compound aflA4) of the present invention is as follows.

11−ヒドロキシ−トリム−8−エン−12・13−ジ
オイック酸13−メチルエステル11→12−ラクトン
(11−Hydroxy −dri m −8−en−
12・13−dioic Ac1d 13−Meth
ylEsterll→12−Lactone ) 。
11-Hydroxy-trim-8-en-12,13-dioic acid 13-methyl ester 11→12-lactone (11-Hydroxy-drim-8-en-
12・13-dioic Ac1d 13-Meth
ylEsterll→12-Lactone).

なお、生成物の命名はドリマン型骨格に従って命名した
The products were named according to the Doliman-type skeleton.

以下、本発明を実施例で説明するが、 何らこれらに限定されるものではない。The present invention will be explained below with reference to Examples. It is not limited to these in any way.

実施例 1 本発明は 14−OH体(1) 2.0091 (CH2C12:MeOH(1: 1)40m中)をド
ライアイス−アセトン冷却下、オゾンを3時間吹き込み
、室温に戻して10%Pd−C700■を加えて、常圧
接触還元に付す。
Example 1 In the present invention, 14-OH substance (1) 2.0091 (in 40 m of CH2C12:MeOH (1:1)) was cooled with dry ice-acetone, ozone was blown into it for 3 hours, and the mixture was returned to room temperature and 10% Pd- Add C700■ and subject to normal pressure catalytic reduction.

水素が吸収しなくなるまで接触還元を行ない、その後、
1過する。
Catalytic reduction is carried out until hydrogen is no longer absorbed, and then
1 pass.

F液を濃縮後、残渣にエーテルを加え、エーテル層を1
0%KOH溶液で抽出する。
After concentrating solution F, ether was added to the residue, and the ether layer was diluted with 1
Extract with 0% KOH solution.

アルカリ層は10%HCI 溶液で酸性にしてクロロ
ホルムから抽出する。
The alkaline layer is acidified with 10% HCI solution and extracted from chloroform.

クロロホルム層及びエーテル層ハ各々飽和食塩水で洗浄
後、Na2SO4で脱水乾燥してそれぞれ溶媒を留去す
る。
The chloroform layer and the ether layer were each washed with saturated brine, dehydrated and dried over Na2SO4, and the solvents were distilled off.

クロロホルム層は溶媒留去後、更にジアゾメタン−エー
テル溶液を加えてメチル化後、エーテルを留去する。
After distilling off the solvent, the chloroform layer is further methylated by adding a diazomethane-ether solution, and then the ether is distilled off.

エーテル層(中性部) 油状物 594m9 GLC:4A 1.5% 0V−17,シマライト(
Shimalite ) に担持、温度220℃ jR=3.8.4.45分その他多くありクロロホルム
層(酸性部) 油状物 1.243r GLC: 4A 1.5% 0V−17シマライト(
Shimalite ) に担持、温度220℃ tR=2.95.1.05分、その他ありシリカゲル8
0Pを用いてカラムクロマトグラフに付し、エーテルの
溶出部をエーテル−n−ヘキサンから再結晶して無色プ
リズム吊3)271■(15%)を得る。
Ether layer (neutral part) Oil 594m9 GLC:4A 1.5% 0V-17, Simalite (
Supported on Shimalite), temperature 220℃ jR = 3.8.4.45 minutes and many others Chloroform layer (acidic part) Oily substance 1.243r GLC: 4A 1.5% 0V-17 Shimalite (
Supported on Shimalite), temperature 220°C tR = 2.95.1.05 minutes, others available Silica gel 8
The product was subjected to column chromatography using 0P, and the ether eluate was recrystallized from ether-n-hexane to obtain colorless Prism 3) 271 (15%).

(3) : mp 195〜196゜ 元素分析(C16H2205として) 理論値:C65,29R7,53 ☆ 14−OHHI31.44 S’ (CH2C12:
MeOH(1:1)22.8ml中)をドライアイス−
アセトン冷却下、オゾンを2時間吹き込み、室温に戻し
て亜硫酸ナトリウム水溶液(Na25o34 ?→H2
O80m旬を加えて、室温で2時間攪拌後、10%MC
I で酸性にしてクロロホルムから抽出する。
(3): mp 195-196° Elemental analysis (as C16H2205) Theoretical value: C65,29R7,53 ☆ 14-OHHI31.44 S' (CH2C12:
MeOH (1:1) in 22.8 ml) on dry ice.
While cooling with acetone, ozone was blown in for 2 hours, the temperature was returned to room temperature, and a sodium sulfite aqueous solution (Na25o34?→H2
Add O80m and stir at room temperature for 2 hours, then add 10% MC.
Acidify with I and extract from chloroform.

クロロホルム層を飽和食塩水で洗浄後、Na 2 SO
4で脱水乾燥して溶媒を留去する。
After washing the chloroform layer with saturated saline, Na 2 SO
4 to remove the solvent.

残渣(952■)をシリカゲル30Pを用いてカラムク
ロマトに付し、エーテル溶出部をエーテル−n−へキサ
ンから再結晶して無色プリズム晶(3)168m9(1
6%)を得る。
The residue (952cm) was subjected to column chromatography using silica gel 30P, and the ether eluate was recrystallized from ether-n-hexane to give colorless prism crystals (3), 168m9 (1
6%).

これは、実施例1で得られたものとI、R1、N、M、
R,U、V、 が全く一致した。
This is the same as that obtained in Example 1, I, R1, N, M,
R, U, and V completely matched.

実施例 3 14−OH体2)5007V(CH2C12:MeOH
(1:1)10TLl中)をドライアイス−アセトン冷
却下、オゾンを2時間吹き込み、室温に戻して亜硫酸ナ
トリウム水溶液(Na2SO32P、H2O40rIL
l中)を加えて、室温で2時間攪拌後、10%HCI
で酸性にしてクロロホルムから抽出する。
Example 3 14-OH body 2) 5007V (CH2C12:MeOH
(1:1) in 10TLl) was cooled with dry ice-acetone and ozone was blown into it for 2 hours, and the temperature was returned to room temperature.
After stirring at room temperature for 2 hours, add 10% HCl
acidify and extract from chloroform.

クロロホルム層を飽和食塩水で洗浄後、Na2SO4で
脱水乾燥して溶媒を留去する。
The chloroform layer was washed with saturated brine, dehydrated and dried over Na2SO4, and the solvent was distilled off.

残渣(484Tn9)をシリカゲル301を用いてカラ
ムクロマトに付し、エーテル:石油エーテル−1:10
溶出部をエーテル−n−ヘキサンから再結晶して無色プ
リズム晶(4)1271v(25%)を得る。
The residue (484Tn9) was subjected to column chromatography using silica gel 301, and ether: petroleum ether - 1:10
The eluate was recrystallized from ether-n-hexane to obtain colorless prism crystals (4) 1271v (25%).

これは、実施例1で得られたものと1.Ro、N、M、
R,、U、V、が全く一致した。
This is the same as that obtained in Example 1 and 1. Ro, N, M,
R,, U, and V completely matched.

実施例 4 ヒドロキシラクトン(3)17911I9(50%V/
V)EtOH−H2O5ml中)を50%(V/V)E
tOH−H2O溶液に溶かし、水冷攪拌下NaBH42
001FM&を加えて30分間攪拌する。
Example 4 Hydroxylactone (3) 17911I9 (50% V/
V) EtOH-H2O in 5 ml) at 50% (V/V) E
Dissolved in tOH-H2O solution and stirred with water cooling NaBH42
Add 001FM& and stir for 30 minutes.

その後、水を加えてエーテルから抽出する。Then add water and extract from ether.

エーテル層を飽和食塩水で洗浄後、Na2SO4で脱水
乾燥して溶媒留去すると油状物(4)100即を得る。
The ether layer was washed with saturated brine, dehydrated and dried over Na2SO4, and the solvent was distilled off to obtain 100 g of oil (4).

(4)二油状物 元素分析(高分解能質量分析による。(4) Two oily substances Elemental analysis (by high-resolution mass spectrometry).

C15H2204として) 14−OH体(1)1.087 ? (CH2Cl 2
:MeOH(1: 1)22ml中)ヲトライアイ
スーアセトン冷却下、オゾンを1時間吹き込み、室温に
戻してNaBH4(8001Q) −50%(V/V)
EtOH−H2O(10ml1)溶液を加えて30分間
攪拌する。
(as C15H2204) 14-OH form (1) 1.087? (CH2Cl2
: MeOH (1:1) in 22 ml) under cooling with acetone, ozone was blown into the mixture for 1 hour, the temperature was returned to room temperature, and NaBH4 (8001Q) -50% (V/V)
Add EtOH-H2O (10ml1) solution and stir for 30 minutes.

その後、水を加えてエーテルから抽出する。Then add water and extract from ether.

エーテル層を飽和食塩水で洗浄後、Na25O,で脱水
乾燥して溶媒を留去する。
The ether layer was washed with saturated brine, dehydrated and dried over Na25O, and the solvent was distilled off.

残渣(787rrI9)をシリカゲル50Pを用いてカ
ラムクロマトグラフに付し、石油エーテル:ニーデル=
2:1の溶出部から油状物4)446■(49%)を得
る。
The residue (787rrI9) was subjected to column chromatography using silica gel 50P, petroleum ether: needle=
The 2:1 eluate yields an oil 4) 446 .mu.m (49%).

これは、実施例4で得られたものと1.R,、N、M、
R,が全く一致した。
This is the same as that obtained in Example 4 and 1. R,,N,M,
R, completely matched.

実施例 6 14−OH体2)500■ (CH2C12:MeOH(1: 1)10ml中)を
ドライアイス−アセトン冷却下、オゾンを30分間吹き
込み、室温に戻してNaBH4(4001n9)−50
%(v/v)EtOH−H2O(5rul)溶液を加え
て30分間攪拌する。
Example 6 14-OH compound 2) 500■ (in 10 ml of CH2C12:MeOH (1:1)) was cooled with dry ice-acetone, ozone was blown into it for 30 minutes, the temperature was returned to room temperature, and NaBH4 (4001n9)-50
% (v/v) EtOH-H2O (5 rul) solution and stir for 30 minutes.

その後、水を加えてエーテルから抽出する。Then add water and extract from ether.

エーテル層を飽和食塩水で洗浄後、Na2SO4で脱水
乾燥して溶媒を留去する。
The ether layer was washed with saturated brine, dehydrated and dried over Na2SO4, and the solvent was distilled off.

残渣(300■)をシリカゲル30fを用いてカラムク
ロマトに付し、石油エーテル:エーテル=2:1の溶出
部から油状ajlA4)233TI9(48%)を得る
The residue (300 μm) was subjected to column chromatography using silica gel 30f, and oily ajlA4) 233TI9 (48%) was obtained from the eluate of petroleum ether:ether=2:1.

これは、実施例4で得られたものとI、R,、N、1M
、R,が全く一致した。
This is the same as that obtained in Example 4 and I,R,,N,1M
, R, were completely consistent.

Claims (1)

【特許請求の範囲】[Claims] で表わされるセスキテルペン誘導体化合物。A sesquiterpene derivative compound represented by
JP4533980A 1980-04-07 1980-04-07 Sesquiterpene derivative compounds Expired JPS5850222B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4533980A JPS5850222B2 (en) 1980-04-07 1980-04-07 Sesquiterpene derivative compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4533980A JPS5850222B2 (en) 1980-04-07 1980-04-07 Sesquiterpene derivative compounds

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP10838676A Division JPS5334768A (en) 1976-09-09 1976-09-09 Preparation of diterpene derivatives

Publications (2)

Publication Number Publication Date
JPS55153780A JPS55153780A (en) 1980-11-29
JPS5850222B2 true JPS5850222B2 (en) 1983-11-09

Family

ID=12716529

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4533980A Expired JPS5850222B2 (en) 1980-04-07 1980-04-07 Sesquiterpene derivative compounds

Country Status (1)

Country Link
JP (1) JPS5850222B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001024808A1 (en) * 1999-10-06 2001-04-12 Bioactiva Microtechne Canelo products and methods of making and using same

Also Published As

Publication number Publication date
JPS55153780A (en) 1980-11-29

Similar Documents

Publication Publication Date Title
US2883384A (en) Production of reserpine and analogs thereof
Sweat et al. Dimethyl sulfoxide oxidations
Jefford et al. An improved procedure for the preparation of bicyclo [2.2. 2] octa-2, 5, 7-triene (barrelene)
Ibnusaud et al. Chiral γ-butyrolactones related to optically active 2-hydroxycitric acids
Fried et al. Neogermitrine, a New Ester Alkaloid from Veratrum Viride1
Tseng et al. Synthesis of 4a. alpha.-phorbol 9-myristate 9a-acetate and related esters
JPS5850222B2 (en) Sesquiterpene derivative compounds
Gillard et al. π-Facial diastereoselectivity in the Diels–Alder reactions of cis-cyclohexa-3, 5-diene-1, 2-diol and derivatives with N-phenylmaleimide
Salomon et al. Carbonyl-alkyne exchange of 2H-pyrans. A new aryl annelation method
Price et al. Chemistry of Ottonia vahlii. II. Constitution of the nonvolatile component
Bradbury et al. The alkaloids of Senecio jacobaea L. II. The structures of the acids, and the relationship between jacobine and jaconine
Adackaparayil et al. Preparation and reactivity of a new spin label reagent
Edwards et al. Photolysis of a medium-ring nitrosamide
Connolly et al. Constituents of Erythroxylon monogynum Roxb. Part II. Erythroxydiols X, Y, and Z; two novel skeletal types of diterpenoids
Frensch et al. Selective monomer/dimer formation in a many-membered crown ether lactone synthesis
Ito et al. Studies on the constituents of Marsdenia formosana Masamune. II. Structures of marsformoxide A and marsformoxide B
Geisel et al. The Cyclopropylcarbinyl‐Cyclobutyl‐Homoallylic Rearrangement. Part III. Evidence for a symmetrical intermediate and for two discrete rearrangement processes
JPS5850223B2 (en) Sesquiterpene derivative compounds
Crout Pyrrolizidine and seco-pyrrolizidine alkaloids of Crotalaria laburnifolia L. subspecies eldomae
Tahara et al. Diterpenoids. VIII. Synthesis of Skeleton of Diterpene Alkaloid.
SU673174A3 (en) Method of producing 4-dezacetooxyvincristine or salts thereof
Batta et al. Improved synthesis of 5β-cholestan-26-oic acids
JPS5850224B2 (en) Method for producing sesquiterpene derivative compounds
US20020137950A1 (en) Novel chiral derivatives of garcinia acid bearing lactone ring moiety and process for preparing the same
US3041355A (en) Products related to muscarine and the preparation of such products